These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11801513)

  • 21. Management of thyroid eye disease.
    Bartalena L; Marcocci C; Tanda L; Pinchera A
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S458-65. PubMed ID: 12192546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.
    Mourits MP; van Kempen-Harteveld ML; García MB; Koppeschaar HP; Tick L; Terwee CB
    Lancet; 2000 Apr; 355(9214):1505-9. PubMed ID: 10801172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves orbitopathy: correlation of CT and clinical findings.
    Nugent RA; Belkin RI; Neigel JM; Rootman J; Robertson WD; Spinelli J; Graeb DA
    Radiology; 1990 Dec; 177(3):675-82. PubMed ID: 2243967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrine orbitopathy--symptoms, diagnosis, therapy].
    Boergen KP
    Ther Umsch; 1990 Apr; 47(4):270-8. PubMed ID: 2191461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recession of the inferior rectus muscle in Graves' orbitopathy.
    De Hoog J; Stravers S; Kalmann R
    Eye (Lond); 2010 Jun; 24(6):1011-7. PubMed ID: 19911020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
    Lai A; Sassi L; Compri E; Marino F; Sivelli P; Piantanida E; Tanda ML; Bartalena L
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1333-7. PubMed ID: 20061414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of optic neuropathy in endocrine orbitopathy].
    Heinemann B; Bischoff P; Jörgensen J; Weder B
    Klin Monbl Augenheilkd; 1991 May; 198(5):460-1. PubMed ID: 1886385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual motility impairment in endocrine orbitopathy.
    Mühlendyck H
    Dev Ophthalmol; 1989; 20():13-27. PubMed ID: 2591623
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is radiotherapy beneficial for thyroid ophthalmopathy or not?].
    Prat Partomeu J
    Arch Soc Esp Oftalmol; 2003 Mar; 78(3):131-2. PubMed ID: 12677487
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves' ophthalmopathy: a retrospective analysis of 90 cases.
    Van Ruyven RL; Van Den Bosch WA; Mulder PG; Eijkenboom WM; Paridaens AD
    Eye (Lond); 2000 Oct; 14 Pt 5():761-4. PubMed ID: 11116700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid dysfunction: managing the ocular complications of Graves' disease.
    Fries PD
    Geriatrics; 1992 Feb; 47(2):58-60, 63-4, 70. PubMed ID: 1735520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orbital decompression and the treatment of orbitopathy in Graves' disease.
    McCord CD
    J Med Assoc Ga; 1980 Jan; 69(1):27-33. PubMed ID: 6892528
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thyroid orbitopathy].
    Yassur I; Ben Simon GJ; Rosen N
    Harefuah; 2003 May; 142(5):377-80, 396. PubMed ID: 12803064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
    Dietlein M; Dederichs B; Weigand A; Schicha H
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S190-4. PubMed ID: 10614920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid-related orbitopathy: concepts and management.
    Della Rocca RC
    Facial Plast Surg; 2007 Aug; 23(3):168-73. PubMed ID: 17691064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orbitopathy after treatment of Graves' disease.
    Hurley JR
    J Nucl Med; 1994 May; 35(5):918-20. PubMed ID: 8176482
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypofractionated radiotherapy for Graves' orbitopathy.
    Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
    Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral optic nerve edema presenting as initial manifestation of thyroid eye disease.
    Wilson ME; Kim C; Carrasco J
    Orbit; 2016 Oct; 35(5):288-91. PubMed ID: 27486810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.